97 related articles for article (PubMed ID: 1401833)
1. Serum pepsinogen A in atrophic chronic gastritis and in gastric cancer: a distinctive difference in behavior?
Perasso A; Testino G
J Clin Gastroenterol; 1992 Sep; 15(2):164-6. PubMed ID: 1401833
[No Abstract] [Full Text] [Related]
2. Pepsinogen A/pepsinogen C or pepsinogen A multiplied by gastrin in the diagnosis of gastric cancer?
Farinati F; Di Mario F; Plebani M; Cielo R; Fanton MC; Valiante F; Masiero M; De Boni M; Della Libera G; Burlina A
Ital J Gastroenterol; 1991 May; 23(4):194-6. PubMed ID: 1751813
[TBL] [Abstract][Full Text] [Related]
3. Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies.
Cao Q; Ran ZH; Xiao SD
J Dig Dis; 2007 Feb; 8(1):15-22. PubMed ID: 17261130
[TBL] [Abstract][Full Text] [Related]
4. Feasibility and cost-effectiveness of using magnification chromoendoscopy and pepsinogen serum levels for the follow-up of patients with atrophic chronic gastritis and intestinal metaplasia.
Dinis-Ribeiro M; da Costa-Pereira A; Lopes C; Moreira-Dias L
J Gastroenterol Hepatol; 2007 Oct; 22(10):1594-604. PubMed ID: 17845687
[TBL] [Abstract][Full Text] [Related]
5. Agreement of endoscopic findings and serum pepsinogen levels as an indicator of atrophic gastritis.
Inoue M; Kobayashi S; Matsuura A; Hamajima N; Tajima K; Tominaga S
Cancer Epidemiol Biomarkers Prev; 1998 Mar; 7(3):261-3. PubMed ID: 9521444
[TBL] [Abstract][Full Text] [Related]
6. [Detection of gastric preneoplastic lesions with serum levels of pepsinogen in Chilean subjects].
Fernández F JI; de Aretxabala U X; Santander D R; Sabah T S; Maira S J; Navarro R A; Planzer D M; Gómez L F; Etchart M; Gallegos I; Torrens X; Fasce P G; Reydet I
Rev Med Chil; 2007 Dec; 135(12):1519-25. PubMed ID: 18357351
[TBL] [Abstract][Full Text] [Related]
7. Qualitative and quantitative determinations of pepsinogen I in gastric cancer and premalignant changes of the stomach.
Westerveld BD; Pals G; Défize J; Pronk J; Frants RR; Kreuning J; Eriksson AW; Meuwissen SG
Prog Clin Biol Res; 1985; 173():201-12. PubMed ID: 3885251
[TBL] [Abstract][Full Text] [Related]
8. Serum pepsinogens in relation to precancerous gastric lesions in a population at high risk for gastric cancer.
You WC; Blot WJ; Zhang L; Kneller RW; Li JY; Jin ML; Chang YS; Zeng XR; Zhao L; Fraumeni JF
Cancer Epidemiol Biomarkers Prev; 1993; 2(2):113-7. PubMed ID: 8467245
[TBL] [Abstract][Full Text] [Related]
9. [Pepsinogen].
Miki K
Nihon Rinsho; 1995 May; 53(5):1198-202. PubMed ID: 7602778
[TBL] [Abstract][Full Text] [Related]
10. Using serum pepsinogens wisely in a clinical practice.
Miki K; Urita Y
J Dig Dis; 2007 Feb; 8(1):8-14. PubMed ID: 17261129
[TBL] [Abstract][Full Text] [Related]
11. The ratio of pepsinogen A to pepsinogen C: a sensitive test for atrophic gastritis.
Borch K; Axelsson CK; Halgreen H; Damkjaer Nielsen MD; Ledin T; Szesci PB
Scand J Gastroenterol; 1989 Sep; 24(7):870-6. PubMed ID: 2799289
[TBL] [Abstract][Full Text] [Related]
12. [Characteristics of enzymatic function of the stomach in gastroduodenal diseases in children with regard to gastric carcinogenesis].
Privorotskiĭ VF; Kalinovskiĭ VP; Aleksandrova VA; Guliaeva IV; Bobrov IuF
Vopr Onkol; 1994; 40(1-3):36-40. PubMed ID: 7701791
[TBL] [Abstract][Full Text] [Related]
13. Relationship between Helicobacter pylori infection, atrophic gastritis and gastric carcinoma in a Japanese population.
Asaka M; Kato M; Kudo M; Katagiri M; Nishikawa K; Yoshida J; Takeda H; Miki K
Eur J Gastroenterol Hepatol; 1995 Aug; 7 Suppl 1():S7-10. PubMed ID: 8574741
[TBL] [Abstract][Full Text] [Related]
14. The usefulness of gastric mass screening using serum pepsinogen levels compared with photofluorography.
Yoshihara M; Sumii K; Haruma K; Kiyohira K; Hattori N; Tanaka S; Kajiyama G; Shigenobu T
Hiroshima J Med Sci; 1997 Jun; 46(2):81-6. PubMed ID: 9232936
[TBL] [Abstract][Full Text] [Related]
15. Non-invasive tests in gastric diseases.
di Mario F; Cavallaro LG
Dig Liver Dis; 2008 Jul; 40(7):523-30. PubMed ID: 18439884
[TBL] [Abstract][Full Text] [Related]
16. Serum anti-Helicobacter pylori IgG antibodies and pepsinogens A and C as serological markers of chronic atrophic gastritis.
Sitas F; Smallwood R; Jewell D; Millard PR; Newell DG; Meuwissen SG; Moses S; Zwiers A; Forman D
Cancer Epidemiol Biomarkers Prev; 1993; 2(2):119-23. PubMed ID: 8467246
[TBL] [Abstract][Full Text] [Related]
17. Helicobacter pylori infection, but not mucosal atrophy, significantly affects serum pepsinogen level after gastric cancer surgery.
Onoda N; Katsuragi K; Maeda K; Sawada T; Wakasa K; Hirakawa K
Hepatogastroenterology; 2006; 53(70):619-23. PubMed ID: 16995475
[TBL] [Abstract][Full Text] [Related]
18. Cautious comparison between East and West is necessary in terms of the serum pepsinogen test.
Miki K; Fujishiro M
Dig Endosc; 2009 Apr; 21(2):134-5. PubMed ID: 19691790
[No Abstract] [Full Text] [Related]
19. [The variation and clinical significance of serum pepsinogen subgroups in atrophic gastritis and gastric cancer].
Jin HO; Zhang GZ; Kong XT
Zhonghua Nei Ke Za Zhi; 1986 Oct; 25(10):608-10, 637-8. PubMed ID: 3568844
[No Abstract] [Full Text] [Related]
20. Importance of atrophic gastritis in diagnostics and prevention of gastric cancer: application of plasma biomarkers.
Sipponen P; Graham DY
Scand J Gastroenterol; 2007 Jan; 42(1):2-10. PubMed ID: 17190755
[No Abstract] [Full Text] [Related]
[Next] [New Search]
